Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study were to determine factors associated with NAC use, to more clearly define reasons for low utiliza...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, N. G., Chen, Y., Downs, T. M., Bochner, B. H., Apolo, A. B., Porter, M. P., La Rochelle, J. C., Amling, C. L., Koppie, T. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058463/
https://www.ncbi.nlm.nih.gov/pubmed/24982672
http://dx.doi.org/10.1155/2014/746298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058463/
https://www.ncbi.nlm.nih.gov/pubmed/24982672
http://dx.doi.org/10.1155/2014/746298

Ejemplares similares